Global Sleep Disorder Treatment Market research report contains thorough information about target markets or customers. Analytical study of this market report aids in formulating growth strategies to augment sales and build brand image in the market. This market report supports the business to take better decisions for the successful future planning in terms of current and future trends in particular product or the industry. The key factors of Global Sleep Disorder Treatment Market report consist of primary research, benchmarking studies, secondary research, company profiles, competitive intelligence & reporting, syndicated research, data collection, data processing and analysis, survey design, and survey programming.
Data Bridge Market Research analyses that the sleep disorder treatment market which was USD 8551.42 million in 2021, would rocket up to USD 16914.58 million by 2029, and is expected to undergo a CAGR of 8.90% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sleep-disorder-treatment-market&Shri
Growing level of stress is expected to drive the market’s growth rate
Increased work-related stress adds to the rise of the insomnia market. Workload increases and demanding work schedules result in poor sleep quality. Furthermore, many people work unusual time shifts, such as security personnel, and the manufacturing industries run 24 hours a day, seven days a week. These irregular work shifts have an impact on the quality and cycle of sleep. Furthermore, the increase in the number of insomnia centers and sleep diagnostic centers contributes to the market’s growth. Insomnia treatment centers help people improve their sleep quality, and sleep diagnostic centers serve as diagnostic laboratories for diagnosing sleep problems. Furthermore, the market is growing as more people choose non-pharmacological sleep therapy. Insomnia is frequently related with a person’s mental state.
Segment Analysis:
The sleep disorder treatment market is segmented on the basis of type, treatment, route of administration, drugs type, population type, end user and distribution channel.
- On the basis of type, the sleep disorder treatment market is segmented into insomnia, sleep Apnea, restless legs syndrome (RLS), narcolepsy and others. Insomnia segment is dominating the market and is growing with the highest CAGR of 9.10% due to augmented pipeline products for the cure of the sleep disorders by major market players.
- On the basis of treatment, the sleep disorder treatment market is segmented into pharmacological therapy, mechanical therapy, mandibular advancement devices, hypoglossal nerve stimulator, surgery and others.
Pharmacological therapy segment of treatment segment is anticipated to dominate the sleep disorder treatment market
Pharmacological therapy segment is dominating the market and is growing with the highest CAGR of 10.00% because of the safe and economical form of administration leading to augmented uptake by the suffered patients.
- On the basis of route of administration, the sleep disorder treatment market is segmented into oral, parenteral and others. Oral segment is dominating the market and is growing with the highest CAGR of 9.10% because of the easy availability and economical nature of the generics drugs for the treatment of the sleep disorder.
- On the basis of drugs type, the sleep disorder treatment market is segmented into branded and generics.
Generics segment of drugs type segment is anticipated to dominate the sleep disorder treatment market
Generics segment is dominating the market and is growing with the highest CAGR of 9.30% due to the presence of the U.S. FDA approved pharmacological therapies for the cure of sleep disorder in adults
- On the basis of population type, the sleep disorder treatment market is segmented into children and adults. Adults segment is dominating the market and is growing with the highest CAGR of 9.10% because hospitals are the main location visited by patients for any surgery or procedure.
- On the basis of end user, the sleep disorder treatment market is segmented into hospitals, specialty clinics, home healthcare, ambulatory surgical center and others. Hospitals segment is dominating the market and is growing with the highest CAGR of 9.20% because direct tender fulfils the requirement of patients and physicians.
- On the basis of distribution channel, the sleep disorder treatment market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. Direct tender segment is dominating the market and is growing with the highest CAGR of 9.5% because most of the facilities procure from direct tenders.
Some of the major players operating in the sleep disorder treatment market are:
- Jazz Pharmaceuticals, Inc. (Ireland)
- Pfizer Inc. (U.S.)
- Viatris Inc. (U.S.)
- Arbor Pharmaceuticals Inc. (U.S.)
- Aurobindo Pharma USA (U.S.)
- Sanofi (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Amneal Pharmaceuticals LLC (U.S.)
- Lupin Pharmaceuticals, Inc. (India)
- Taj Pharmaceuticals Limited (India)
- Eli Lilly and Company (U.S.)
- Mallinckrodt (U.K.)
- Alembic Pharmaceuticals Limited (India)
- Apotex Inc. (Canada)
- Dr. Reddy’s Laboratories Ltd. (India)
- Teva Pharmaceuticals Industries Ltd. (India)
- Taro Pharmaceutical Industries Ltd. (U.S.)
- DeVilbiss Healthcare LLC (U.S.)
- ResMed (U.S.)
To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-sleep-disorder-treatment-market?Shri
Market Development
- In 2020, Jazz Pharmaceuticals plc announced in July that the FDA had approved its new medicine Xyway for the treatment of excessive daytime sleepiness and cataplexy in persons with narcolepsy over the age of 15 years. The FDA has authorised this novel treatment for sleep disorders. As a result, it has raised market demand and sales for its drug, resulting in greater revenue in the approaching period.
- In 2022, Idorsia commercially introduced Quviviq, an insomnia medicine, in May, with 500 sales agents and plans for a ‘Robust’ DTC campaign. Quviviq is a first-in-class, orexin receptor antagonist, which means it works by blocking the action of orexin, a neurotransmitter that is involved in wakefulness. The drug was approved by the US Food and Drug Administration (FDA) in January 2022 for the treatment of adults with insomnia who have difficulty falling asleep or staying asleep.
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
What to Expect from the Report, a 7-Pointer Guide
- The Sleep Disorder Treatment Market report dives into the holistic Strategy and Innovation for this market ecosystem
- The Sleep Disorder Treatment Market report keenly isolates and upholds notable prominent market drivers and barriers
- The Sleep Disorder Treatment Market report sets clarity in identifying technological standardization as well as the regulatory
- framework, besides significantly assessing various implementation models besides evaluation of numerous use cases
- The Sleep Disorder Treatment Market report is also a rich repository of crucial information across the industry, highlighting details on novel investments as well as stakeholders and relevant contributors and market participants.
- A thorough market analytical survey and forecast references through the forecast tenure, encapsulating details on historical developments, concurrent events as well as future growth probability
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-sleep-disorder-treatment-market&Shri
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- [email protected]
.
